Purposeful Company
Purposeful discovers new treatments and develops pharmaceutical products for rare diseases by repurposing previously marketed drugs. Their vision is to fully utilize AI repurposing and revisit rare and common diseases to reverse disease phenotypes. It collaborates with FRAXA and FRAXA-DVI to identify drug repurposing candidates for Fragile X Syndrome. They also identify drug repurposing candidates for Glioblastoma.
Founded Date:
2018-01-01
Last Funding Date:
2018-10-18
Industry:
Quantum Biology
Total Funding:
200000
Headquarters:
Athens,Attiki,Greece,Europe
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
200000
Last Funding Total Usd:
200000
Last Funding Total Currency:
USD
Last Funding Total Value:
200000
Founders:
Charalampos Chomenidis,George Drakakis